queixo sagrado Grande carvalho valerjans kauss lagoa densidade membros
Tackling the Limitations of Copolymeric Small Interfering RNA Delivery Agents by a Combined Experimental-Computational Approach.,Biomacromolecules - X-MOL
Пасхальный турнир в г. Бауске по шашкам 64 по 15 минут и блитц по 9 туров 30.03.18 | dambrete
Methylprenyl and Prenyl Protection for Sulfonamides
Valerjans KAUSS
Diastereoselectivity in the Overman rearrangement of O-cyclohexylideneethylimidates - ScienceDirect
Valerjans KAUSS | Dr. Chem. | Latvian Institute of Organic Synthesis, Riga | Latvian IOS | Department of Medicinal Chemistry
Team - Justso
The synthesis of 3-amino-3-methylbicyclo[3.3.1]nonanes: Endo-selectivity in the Ritter reaction of 1,3,5,7α- tetramethylbicyclo
Valerjans Kauss - Head of Laboratory - Latvian Institute of Organic Synthesis | LinkedIn
President
US6034134A - 1-Amino-alkylcyclohexane NMDA receptor antagonists - Google Patents
Discovery, synthesis, and structure–activity relationships of 2-aminoquinazoline derivatives as a novel class of metabotropic glutamate receptor 5 negative allosteric modulators - ScienceDirect
Team - Justso
Collection of Bioactive Reference Compounds for Focused Library Design - Schneider - 2003 - QSAR & Combinatorial Science - Wiley Online Library
WO2016159745A1 - Ethynylxanthines, preparation and use for cancer treatment - Google Patents
LU fotoarhīvs. Zinātnes kafejnīca - "Kā noveco smadzenes"
Peteris TRAPENCIERIS | Head of Department | PhD | Latvian Institute of Organic Synthesis, Riga | Latvian IOS | Department of Organic Chemistry
Valerjans Kauss - Head of Laboratory - Latvian Institute of Organic Synthesis | LinkedIn
Sumina Latvijas gudrākos prātus | LA.LV
Valerjans Kauss | 2° International Scientific School | Novel Psychoactive Substances: focus on Novel Synthetic Opioids
Foto | LETA
RTU Doktorantūras absolventu gadagrāmata 2015 by Santa Rendore - issuu
Valerjans Kauss - Head of Laboratory - Latvian Institute of Organic Synthesis | LinkedIn
Full article: Synthesis of 3,4-dihydro-2H-1,2-benzothiazine-3-carboxylic acid 1,1-dioxides and their evaluation as ligands for NMDA receptor glycine binding site